OTCPK:MEDVF - Post by User
Post by
CerealKilleron Feb 04, 2021 6:39pm
210 Views
Post# 32479768
My theory
My theoryThis is only a theory, but it's the only thing I can think of that makes sense. The stalled stock price and late financials is previously agreed upon coordination between Canaccord and Medivolve from their bought deal in order to allow Canaccord time to accumulate as many shares as possible. 1) April is an awfully long time between last financials and these ones. 2) Canaccord can't sell their shares of .25 from the bought deal for 4 months. 3) An April financial report is just beyond the date Canaccord is allowed to sell. 4) Therefore, there's no immediate rush for Canaccord to make sure the SP is as high as possible before selling (and it doesn't really matter much to Medivolve in the near term either). 5) This allows Canaccord two/three months to try and accumulate as many shares as they can. 6) With a majority/very large position Canaccord can then hold their shares tight, raising the price, and at some point during the run-up, release an official target price of $1 or $2 or whatever, further strengthening the run-up. 7) This might even get the SP above .80 for 10 consecutive trading days which triggers Canaccord's option to purchase warrants for common shares at just .40.